Insider · CIK 0002023732
Gregory Austin Ciongoli
directorownerother
Files at ATRA (Atara Biotherapeutics, Inc.), GOSS (Gossamer Bio, Inc.), ZYME (Zymeworks Inc.). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 23, 2026 | GOSS Gossamer Bio, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +30,000 | $0.00 | $0 | 30,000 | 17 d ago |
| Aug 12, 2025 | ZYME Zymeworks Inc. | AGrant or award Common Stock | +415,000 | $12.02 | $5.0M | 488,500 | Aug 12, 2025 |
| Aug 11, 2025 | ZYME Zymeworks Inc. | AGrant or award Stock Option (Right to Buy)derivative | +62,000 | $0.00 | $0 | 62,000 | Aug 12, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.